↓ Skip to main content

Emodin enhances osteogenesis and inhibits adipogenesis

Overview of attention for article published in BMC Complementary Medicine and Therapies, February 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Emodin enhances osteogenesis and inhibits adipogenesis
Published in
BMC Complementary Medicine and Therapies, February 2014
DOI 10.1186/1472-6882-14-74
Pubmed ID
Authors

Feng Yang, Pu-wei Yuan, Yang-Quan Hao, Zheng-Mao Lu

Abstract

It has been suggested that the formation of osteoblasts in bone marrow is closely associated with adipogenesis, and the balance between osteogenesis and adipogenesis differentiation of MSCs (mesenchymal stem cells) is disrupted in osteoporosis. In order to improve the treatment of osteoporosis, available agents with roles of regulating the balance is highly desirable. Emodin is a natural anthraquinone derivative extracted from Chinese herbs, which have been used to treat bone diseases for thousands of years. However, the underlying molecular mechanisms of emodin in modulating osteogenesis and adipogenesis remain poorly understood.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 31 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 22%
Student > Ph. D. Student 5 16%
Researcher 4 13%
Student > Doctoral Student 3 9%
Lecturer 2 6%
Other 6 19%
Unknown 5 16%
Readers by discipline Count As %
Medicine and Dentistry 6 19%
Biochemistry, Genetics and Molecular Biology 5 16%
Agricultural and Biological Sciences 2 6%
Nursing and Health Professions 2 6%
Immunology and Microbiology 1 3%
Other 4 13%
Unknown 12 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2014.
All research outputs
#20,242,136
of 22,769,322 outputs
Outputs from BMC Complementary Medicine and Therapies
#2,971
of 3,623 outputs
Outputs of similar age
#191,817
of 223,261 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#86
of 93 outputs
Altmetric has tracked 22,769,322 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,623 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 223,261 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.